White & Case-Led Apollomics To Go Public Via SPAC Merger
Cancer drugmaker Apollomics Inc. said Wednesday it will merge with blank-check company Maxpro Capital Acquisition Corp., with White & Case LLP and Nelson Mullins Riley & Scarborough LLP guiding the companies...To view the full article, register now.
Already a subscriber? Click here to view full article